EUVIMEDEUVIMED entdecken
Metaanalyse

Intravenous Iron in Heart Failure Patients With Iron Deficiency: A Meta‐Analysis of Randomized Controlled Trials

Yangguang Liu, Jiahuan Li, Yingwen Chen, Lingxiao Li, Ling Zhao, Xiaomei Zhang, Yuli Huang iD

Journal of Evidence-Based Medicine · 2025

DOI: 10.1111/jebm.70057 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Evidence-Based Medicine, 2025. Verfasst von Yangguang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China. Hauptthemen laut MEDLINE: Heart Failure, Iron, Anemia, Iron-Deficiency. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Guangdong Basic and Applied Basic Research Fund, Guangzhou Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of intravenous iron therapy in heart failure (HF) patients with iron deficiency (ID) is still controversial.

Method

We performed an extensive search of electronic databases for pertinent studies, encompassing all records up to March 4, 2024. Using random‐effects models in a meta‐analysis, the collected outcomes data were then synthesized and analyzed.

Result

Fourteen trials with 7786 participants (iron therapy: n = 3994; control: n = 3792) were included. Intravenous iron therapy can decrease the risk of composite events of total hospitalization for HF and cardiovascular (CV) death (RR = 0.82 [0.72, 0.92]), total hospitalization for HF (RR = 0.78 [0.66, 0.91]), first hospitalization for HF and CV death (OR = 0.78 [0.65, 0.93]), CV death (OR = 0.86 [0.76, 0.98]), first hospitalization for HF(OR = 0.77 [0.61, 0.99]), but not significantly reduce the risk of all‐cause mortality (OR = 0.93 [0.83, 1.04]). Furthermore, intravenous iron treatment can improve the distance of 6‐min walking test (6MWT) (WMD = 18.99 [7.41, 30.57]). Subgroup analyses found that intravenous iron may be more beneficial in HF patients with transferrin saturation (TSAT)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureIronAnemia, Iron-DeficiencyHumansRandomized Controlled Trials as TopicAdministration, IntravenousHospitalization

Stichwörter der Autor:innen

cardiovascular deathferric carboxymaltoseheart failurehospitalizationintravenous ironiron deficiencymortality

Substanzen

Iron

Autor:innen und Institutionen

  • Department of Cardiology, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
  • Department of Cardiology, the Lecong Hospital of Shunde, Foshan, China.
  • Faculty of Medicine, The George Institute For Global Health, University of New South Wales, Sydney, Australia.

ORCID-Profile: Yuli Huang

Förderung

  • National Natural Science Foundation of China
  • The Guangdong Basic and Applied Basic Research Fund
  • Guangzhou Science and Technology Plan Project
  • The Scientific Research Start Plan of the Eighth Affiliated Hospital, Southern Medical University
  • The Clinical Research Startup Program of the Eighth Affiliated Hospital, Southern Medical University
  • Science and Technology Innovation Project from Foshan, Guangdong
  • The Clinical Research Startup Program of Shunde Hospital, Southern Medical University

Zitieren

APA

Liu, Y., Li, J., Chen, Y., Li, L., Zhao, L., Zhang, X., & Huang, Y. (2025). Intravenous Iron in Heart Failure Patients With Iron Deficiency: A Meta‐Analysis of Randomized Controlled Trials. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70057

Vancouver

Liu Y, Li J, Chen Y, Li L, Zhao L, Zhang X, et al. Intravenous Iron in Heart Failure Patients With Iron Deficiency: A Meta‐Analysis of Randomized Controlled Trials. Journal of Evidence-Based Medicine. 2025. doi:10.1111/jebm.70057

BibTeX
@article{Liu2025,
  author = {Liu, Yangguang and Li, Jiahuan and Chen, Yingwen and Li, Lingxiao and Zhao, Ling and Zhang, Xiaomei and Huang, Yuli},
  title = {Intravenous Iron in Heart Failure Patients With Iron Deficiency: A Meta‐Analysis of Randomized Controlled Trials},
  journal = {Journal of Evidence-Based Medicine},
  year = {2025},
  doi = {10.1111/jebm.70057}
}
Kostenlos starten →